{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:54:24Z","timestamp":1789055664312,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.nmd.2026.106388","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:56:43Z","timestamp":1772207803000},"page":"106388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Liver health in myotubular and centronuclear myopathies: a patient-driven data collection study to better understand liver health and improve standards of care"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8045-0972","authenticated-orcid":false,"given":"Julie","family":"Bohill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anando","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tmirah","family":"Haselkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Kyrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Beggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Reghan","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Marini-Bettolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.nmd.2026.106388_bib0001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.22119","article-title":"RYR1 mutations are a common cause of congenital myopathies with central nuclei","volume":"68","author":"Wilmshurst","year":"2010","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.nmd.2026.106388_bib0002","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.nmd.2018.06.012","article-title":"An integrated modelling methodology for estimating the prevalence of centronuclear myopathy","volume":"28","author":"Vandersmissen","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2026.106388_bib0003","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.jnen.0000171653.17213.2e","article-title":"X-linked myotubular and centronuclear myopathies","volume":"64","author":"Pierson","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2026.106388_bib0004","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JND-180309","article-title":"Centronuclear myopathies under attack: a plethora of therapeutic targets","volume":"5","author":"Tasfaout","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"9","key":"10.1016\/j.nmd.2026.106388_bib0005","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/6.9.1505","article-title":"Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC international consortium on myotubular myopathy. European neuro-muscular center","volume":"6","author":"Laporte","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.nmd.2026.106388_bib0006","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0168-9525(01)02245-4","article-title":"The myotubularin family: from genetic disease to phosphoinositide metabolism","volume":"17","author":"Laporte","year":"2001","journal-title":"Trends Genet"},{"issue":"1","key":"10.1016\/j.nmd.2026.106388_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2026.106388_bib0008","series-title":"X-Linked myotubular myopathy","author":"Dowling","year":"2002"},{"issue":"2","key":"10.1016\/j.nmd.2026.106388_bib0009","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","article-title":"Medical complications in long-term survivors with X-linked myotubular myopathy","volume":"134","author":"Herman","year":"1999","journal-title":"J Pediatr"},{"issue":"13","key":"10.1016\/j.nmd.2026.106388_bib0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.0000000000004415","article-title":"A natural history study of X-linked myotubular myopathy","volume":"89","author":"Amburgey","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2026.106388_bib0011","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JND-210781","article-title":"INCEPTUS natural history, run-in study for gene replacement clinical trial in X-linked myotubular myopathy","volume":"9","author":"Dowling","year":"2022","journal-title":"J Neuromuscul Dis"},{"issue":"6","key":"10.1016\/j.nmd.2026.106388_bib0012","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00401-017-1748-0","article-title":"Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues","volume":"134","author":"Biancalana","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"4\u20135","key":"10.1016\/j.nmd.2026.106388_bib0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.nmd.2016.02.004","article-title":"Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers","volume":"26","author":"Savarese","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2026.106388_bib0014","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1212\/NXG.0000000000000513","article-title":"Manifesting carriers of X-linked myotubular myopathy","volume":"6","author":"Souza","year":"2020","journal-title":"Neurol Genet"},{"issue":"16","key":"10.1016\/j.nmd.2026.106388_bib0015","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008316","article-title":"Adult MTM1-related myopathy carriers: classification based on deep phenotyping","volume":"93","author":"Cocanougher","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2026.106388_bib0016","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1212\/WNL.0000000000012236","article-title":"Spectrum of clinical features in X-linked myotubular myopathy carriers: an international questionnaire study","volume":"97","author":"Reumers","year":"2021","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2026.106388_bib0017","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng1657","article-title":"Mutations in dynamin 2 cause dominant centronuclear myopathy","volume":"37","author":"Bitoun","year":"2005","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.nmd.2026.106388_bib0018","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/brain\/awu272","article-title":"Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations","volume":"137","author":"B\u00f6hm","year":"2014","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nmd.2026.106388_bib0019","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nmd.2007.01.016","article-title":"Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"17","author":"Jungbluth","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2026.106388_bib0020","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng2086","article-title":"Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy","volume":"39","author":"Nicot","year":"2007","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.nmd.2026.106388_bib0021","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajhg.2014.07.004","article-title":"SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy","volume":"95","author":"Agrawal Pankaj","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"14","key":"10.1016\/j.nmd.2026.106388_bib0022","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","article-title":"Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy","volume":"81","author":"Ceyhan-Birsoy","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nmd.2026.106388_bib0023","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0883073812436605","article-title":"Consensus statement on standard of care for congenital myopathies","volume":"27","author":"Wang","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2026.106388_bib0024","unstructured":"Colombo S., Cowling B., Eyler L., Nijkamp D., Freitag C., Thielemans L., et al. Liver function in X-linked myotubular myopathy and autosomal dominant centronuclear myopathy: data of the unite-CNM study. J Neuromuscul Dis. 0(0):22143602251329215."},{"issue":"12","key":"10.1016\/j.nmd.2026.106388_bib0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1474-4422(23)00313-7","article-title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","volume":"22","author":"Shieh","year":"2023","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.nmd.2026.106388_bib0026","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1474-4422(23)00416-7","article-title":"Gene therapy for X-linked myotubular myopathy: the challenges","volume":"22","author":"Voermans","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2026.106388_bib0027","unstructured":"ASPIRO: a phase 1\/2\/3, randomized, open-label, ascending-dose, delayed-treatment concurrent control clinical study to evaluate the safety and efficacy of AT132, an AAV8-delivered gene therapy in X-linked myotubular Myopathy (XLMTM) patients [Internet]. 2017. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03199469."},{"key":"10.1016\/j.nmd.2026.106388_bib0028","unstructured":"Patient Communications final July [press release]. 06-07-2022 2022."},{"key":"10.1016\/j.nmd.2026.106388_bib0029","unstructured":"A phase 1\/2 trial on the safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of DYN101 in patients \u2265 16 years of age with centronuclear myopathies caused by mutations in DNM2 or MTM1 [Internet]. 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04033159."},{"key":"10.1016\/j.nmd.2026.106388_bib0030","unstructured":"Trust M. Company expects to initiate phase 1 \/2 study \u2018Unite-CNM\u2019 in 2H2019 2019 [available from: https:\/\/myotubulartrust.org\/dynacure-receives-orphan-drug-designation-from-the-us-fda-for-dyn101-an-antisense-medicine-to-treat-rare-disease-centronuclear-myopathies\/."},{"key":"10.1016\/j.nmd.2026.106388_bib0031","unstructured":"TAM4MTM: a phase 1\/2 randomized, placebo-controlled, double-blinded, single crossover study to determine the safety and efficacy of Tamoxifen Therapy for myotubular myopathy (XLMTM) [Internet]. 2021. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04915846."},{"issue":"1","key":"10.1016\/j.nmd.2026.106388_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07057-5","article-title":"Tamoxifen therapy in a murine model of myotubular myopathy","volume":"9","author":"Maani","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nmd.2026.106388_bib0033","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1038\/s41467-018-07058-4","article-title":"Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy","volume":"9","author":"Gayi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2026.106388_bib0034","unstructured":"TAM4MTM Clinical Trial Q&A webinar: myotubular Trust; 2024 [available from: https:\/\/www.youtube.com\/watch?v=VJq-vVWTpL0."},{"key":"10.1016\/j.nmd.2026.106388_bib0035","unstructured":"Baranello G., Dowling J. To the myotubular and centronuclear community Myotubular Trust2024 [updated 21\/11\/2024. Available from: https:\/\/myotubulartrust.org\/tamoxifen-trial-tam4mtm-stopped-due-to-impact-on-liver-function-november-2024\/."},{"issue":"1","key":"10.1016\/j.nmd.2026.106388_bib0036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JND-210712","article-title":"Intrahepatic cholestasis is a clinically significant feature associated with natural history of X-linked myotubular myopathy (XLMTM): a case series and biopsy report","volume":"9","author":"Molera","year":"2022","journal-title":"J Neuromuscul Dis"},{"issue":"16","key":"10.1016\/j.nmd.2026.106388_bib0037","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007319","article-title":"X-linked myotubular myopathy: a prospective international natural history study","volume":"92","author":"Annoussamy","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2026.106388_bib0038","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mus.26018","article-title":"A multicenter, retrospective medical record review of X-linked myotubular myopathy: the recensus study","volume":"57","author":"Beggs","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106388_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.legalmed.2019.04.005","article-title":"An autopsy case of peliosis hepatis with X-linked myotubular myopathy","volume":"38","author":"Funayama","year":"2019","journal-title":"Leg Med (Tokyo)"},{"issue":"1","key":"10.1016\/j.nmd.2026.106388_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s13023-021-02055-1","article-title":"Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies","volume":"16","author":"D\u2019Amico","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.nmd.2026.106388_bib0041","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JND-200539","article-title":"Diagnosing X-linked myotubular myopathy - a German 20-year follow up experience","volume":"8","author":"Gangfuss","year":"2021","journal-title":"J Neuromuscul Dis"},{"issue":"7","key":"10.1016\/j.nmd.2026.106388_bib0042","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nmd.2021.04.009","article-title":"Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy","volume":"31","author":"Neese","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106388_bib0043","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nmd.2023.10.014","article-title":"The myotubular and centronuclear myopathy patient registry: a multifunctional tool for translational research","volume":"35","author":"Bullivant","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106388_bib0044","unstructured":"Community conversations: liver issues in MTM and CNM Youtube: MTM-CNM Family Connection; 2023 [updated 02\/07\/2025. Available from: https:\/\/www.youtube.com\/watch?v=EIWXpZsh0yI."},{"issue":"21","key":"10.1016\/j.nmd.2026.106388_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111377","article-title":"Common pathogenic mechanisms in centronuclear and myotubular myopathies and latest treatment advances","volume":"22","author":"G\u00f3mez-Oca","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2026.106388_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.07.256","article-title":"49P Epidemiologic study of XL-MTM and clinical expression in the liver (EXCEL): study design of an observational, patient-centric study","volume":"43","author":"Beggs","year":"2024","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626000568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626000568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:13:02Z","timestamp":1777342382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896626000568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S0960896626000568"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106388","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver health in myotubular and centronuclear myopathies: a patient-driven data collection study to better understand liver health and improve standards of care","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106388"}}